Metric · Sleep
Adult OSA prevalence (%): market comparison
Adult obstructive sleep apnea prevalence
Dental Market Radar Editorial Team · Updated · Data as of
Across 6 of 12 markets with a value, the highest lead value for adult osa prevalence (%) is Singapore at 30.5% and the lowest is New Zealand at 3.0%. Bases differ by market, so read the comparability rating beside each value.
Key points
- In 2012, the prevalence of obstructive sleep apnea among adults in Singapore was 30.5%, according to Respirology via PubMed Tan A et al. Prevalence of sleep-disordered breathing in a multiethnic Asian population in Singapore. It is the highest lead value among the markets.
- In 2019, the prevalence of obstructive sleep apnea among adults in New Zealand was 3.0%, according to The Lancet Respiratory Medicine Benjafield AV et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med 2019. It is the lowest lead value among the markets.
Cite this
Dental Market Radar (dentalmarketradar.com), Adult OSA prevalence (%) comparison, https://dentalmarketradar.com/metrics/osa-prevalence-adult-pct/
Permanent URL: https://dentalmarketradar.com/metrics/osa-prevalence-adult-pct/. Licensed under CC BY 4.0.
Definition
Adult obstructive sleep apnea prevalence Unit: percent. Category: Sleep.
Chart
Comparison table
| Market | Lead value | Basis | As of | Comparability | Calculation | Source | State |
|---|---|---|---|---|---|---|---|
| Singapore | 30.5% (stale) | estimate | Comparability B | Tan A et al. Prevalence of sleep-disordered breathing in a multiethnic Asian population in Singapore: a community-based study. Respirology 2016;21(5):943-50 | Value (stale) | ||
| Japan | 14.0% (stale) | estimate | Comparability C | Estimation of the global prevalence and burden of obstructive sleep apnoea (Lancet Respir Med 2019) | Value (stale) | ||
| Thailand | 11.4% (stale) | estimate | Comparability B | Tawaranurak K et al. Prevalence, risk factors and clinical manifestation of patients suspected as having OSA in Songklanagarind Hospital Sleep Center. J Health Sci Med Res 2019;37(4):305-312 | Value (stale) | ||
| Vietnam | 8.5% (stale) | estimate | Comparability B | Study about the prevalence of the obstructive sleep apnoea syndrome in Vietnam (EPSASIE), Duong-Quy S et al. | Value (stale) | ||
| Australia | 4.8% (stale) | estimate | Comparability C | Benjafield AV et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med 2019 | Value (stale) | ||
| New Zealand | 3.0% (stale) | estimate | Comparability C | Benjafield AV et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med 2019 | Value (stale) | ||
| Taiwan | No figure found why Chou et al. 2023 report 69.5% OSAS in 1,372 ENT-clinic patients aged 30-70 (home sleep test) - a referred clinical sample, not population prevalence, so not recorded. A modelled national estimate… | estimate | Comparability C | Chou et al. 2023, Prevalence of obstructive sleep apnea using home sleep test in Taiwan, Nature and Science of Sleep 15:1107-1116 | Not available | ||
| South Korea | No figure found why No national adult OSA prevalence located. Best peer-reviewed Korean figure is sex-split and age-limited (40-69 y, Korean Health and Genome Study, community sample n=457 with overnight… | other | Comparability C | Kim J et al. Prevalence of sleep-disordered breathing in middle-aged Korean men and women. Am J Respir Crit Care Med 2004;170:1108-13 | Not available | ||
| Malaysia | No figure found why No reliable figure found. source_id is a placeholder (no sleep source used). Checked: web search for national population-based OSA studies. Why: only local questionnaire studies found (Berlin… | other | Comparability not rated | The dental workforce in Malaysia: drivers for change from the perspectives of key stakeholders (Int Dent J 2020;70:360, doi:10.1111/idj.12575) | Not available | ||
| Saudi Arabia | Not published why No reliable figure found. No national survey value fetched this session. Lead: Benjafield et al., Lancet Respir Med 2019 (modelled country estimates) and national peer-reviewed sleep studies. | other | Comparability C | Statistical Yearbook 2023 (bilingual Arabic/English, 1445H) | Not available | ||
| United Arab Emirates | Not published why No reliable figure found. No national survey value fetched this session. Lead: Benjafield et al., Lancet Respir Med 2019 (modelled country estimates) and national peer-reviewed sleep studies. | other | Comparability C | WHO Global Health Observatory API: NHWA dentists (HWF_0011) and dental expenditure, United Arab Emirates | Not available | ||
| Qatar | Not published why No reliable figure found. No national survey value fetched this session. Lead: Benjafield et al., Lancet Respir Med 2019 (modelled country estimates) and national peer-reviewed sleep studies. | other | Comparability C | Chapter VI Health Services Statistics 2025 (Arabic/English) | Not available |
The headline record leads where one is designated; its basis (for example practising or licensed) and comparability rating are shown next to every value. Per-capita values use the denominator named in the calculation (World Bank total population, same year). Money is shown in US$ at the market exchange rate with local currency beside it.
Markets with no figure
These markets have no published or reliable figure for adult osa prevalence (%). We state why and do not estimate.
- Taiwan: No figure found (gap), we searched and found nothing. See the data record.
- South Korea: No figure found (gap), we searched and found nothing. See the data record.
- Malaysia: No figure found (gap), we searched and found nothing. See the data record.
- Saudi Arabia: Not published (not_published), the authorities do not publish it. See the data record.
- United Arab Emirates: Not published (not_published), the authorities do not publish it. See the data record.
- Qatar: Not published (not_published), the authorities do not publish it. See the data record.
Comparability notes
A: same definition as the metric. B: close to the metric definition; the difference is noted. C: different basis; use with caution when comparing.
- Taiwan: No official or peer-reviewed national figure located
- Japan: Adults aged 30-69 with obstructive sleep apnoea, AHI >=15 events/hour (modelled)
- South Korea: Adults aged 40-69; SDB = AHI>=5/h; OSAS = AHI>=5 plus excessive daytime sleepiness.
- Singapore: Moderate-to-severe sleep-disordered breathing, AHI >=15 events/h on home type-3 monitor (Embletta), adults 21-79
- Thailand: OSA = AHI >=5 events/h; OSAS = OSA plus excessive daytime sleepiness
- Vietnam: OSA syndrome with AHI>5 confirmed by polygraphy/polysomnography among 667 adults screened by questionnaire and RU Sleeping device (EPSASIE study)
- Australia: Adults aged 30-69 with obstructive sleep apnoea, AHI >=15 events/hour (modelled)
- New Zealand: Adults aged 30-69 with obstructive sleep apnoea, AHI >=15 events/hour (modelled)
- Saudi Arabia: Not available
- United Arab Emirates: Not available
- Qatar: Not available
What does Adult OSA prevalence (%) measure?
Adult obstructive sleep apnea prevalence Unit: percent.
Which market has the highest adult osa prevalence (%)?
In 2012, the prevalence of obstructive sleep apnea among adults in Singapore was 30.5%, according to Respirology via PubMed Tan A et al. Prevalence of sleep-disordered breathing in a multiethnic Asian population in Singapore. It is the highest lead value; other markets use different bases, so compare with care.
Which markets have no figure for adult osa prevalence (%)?
No figure is available for Taiwan (we searched and found nothing); South Korea (we searched and found nothing); Malaysia (we searched and found nothing); Saudi Arabia (the authorities do not publish it); United Arab Emirates (the authorities do not publish it); Qatar (the authorities do not publish it). We do not estimate missing figures.
How many markets have data for adult osa prevalence (%)?
6 of 12 markets have a sourced value for adult osa prevalence (%).